BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22532251)

  • 1. A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.
    Hadj-Hamou NS; Laé M; Almeida A; de la Grange P; Kirova Y; Sastre-Garau X; Malfoy B
    Carcinogenesis; 2012 Jul; 33(7):1399-405. PubMed ID: 22532251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization in four angiosarcomas of the female breast.
    Baumhoer D; Gunawan B; Becker H; Füzesi L
    Gynecol Oncol; 2005 May; 97(2):348-52. PubMed ID: 15863129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
    Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
    Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary angiosarcomas after conservation treatment for breast cancers].
    Vojtísek R; Kinkor Z; Fínek J
    Klin Onkol; 2011; 24(5):382-8. PubMed ID: 22070020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
    Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
    Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
    Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
    Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.
    Styring E; Fernebro J; Jönsson PE; Ehinger A; Engellau J; Rissler P; Rydholm A; Nilbert M; Vult von Steyern F
    Breast Cancer Res Treat; 2010 Aug; 122(3):883-7. PubMed ID: 20087653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas.
    Hadj-Hamou NS; Ugolin N; Ory C; Britzen-Laurent N; Sastre-Garau X; Chevillard S; Malfoy B
    Carcinogenesis; 2011 Jun; 32(6):929-34. PubMed ID: 21470956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiosarcoma in a mastectomy scar following irradiation].
    Steiner A; Sulser H
    Schweiz Med Wochenschr; 1991 Mar; 121(12):429-32. PubMed ID: 1851326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy.
    Santi R; Cetica V; Franchi A; Pepi M; Cesinaro AM; Miracco C; Paglierani M; De Giorgi V; Delfino C; Difonzo EM; Pimpinelli N; Bianchi S; Sardi I; Santucci M; Massi D
    Histopathology; 2011 Feb; 58(3):455-66. PubMed ID: 21323968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiosarcomas of the breast: a review of 70 cases.
    Hodgson NC; Bowen-Wells C; Moffat F; Franceschi D; Avisar E
    Am J Clin Oncol; 2007 Dec; 30(6):570-3. PubMed ID: 18091049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.
    Käcker C; Marx A; Mössinger K; Svehla F; Schneider U; Hogendoorn PC; Nielsen OS; Küffer S; Sauer C; Fisher C; Hallermann C; Hartmann JT; Blay JY; Mechtersheimer G; Hohenberger P; Ströbel P
    Genes Chromosomes Cancer; 2013 Jan; 52(1):93-8. PubMed ID: 23012233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous angiosarcoma arising after radiotherapy treatment of a breast carcinoma. Description of a case and review of the literature].
    Di Tommaso L; Fabbri A
    Pathologica; 2003 Aug; 95(4):196-202. PubMed ID: 14577204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects.
    Mayer C; Popanda O; Greve B; Fritz E; Illig T; Eckardt-Schupp F; Gomolka M; Benner A; Schmezer P
    Cancer Lett; 2011 Mar; 302(1):20-8. PubMed ID: 21236564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and secondary angiosarcomas of the breast: a single institution experience.
    Fraga-Guedes C; Gobbi H; Mastropasqua MG; Botteri E; Luini A; Viale G
    Breast Cancer Res Treat; 2012 Apr; 132(3):1081-8. PubMed ID: 22207278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced angiosarcomas.
    Simonart T; Heenen M
    Dermatology; 2004; 209(3):175-6. PubMed ID: 15459528
    [No Abstract]   [Full Text] [Related]  

  • 17. A six-gene signature predicting breast cancer lung metastasis.
    Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
    Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.
    Li X; Cao X; Li X; Zhang W; Feng Y
    Cancer Sci; 2007 Oct; 98(10):1592-6. PubMed ID: 17651454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.